Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$211.93 - $241.33 $2,119 - $2,413
10 Added 0.71%
1,425 $343,000
Q1 2023

May 10, 2023

BUY
$213.32 - $257.83 $7,466 - $9,024
35 Added 2.54%
1,415 $324,000
Q4 2022

Feb 14, 2023

SELL
$203.72 - $248.97 $2,037 - $2,489
-10 Reduced 0.72%
1,380 $324,000
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $22,938 - $29,365
112 Added 8.76%
1,390 $285,000
Q2 2022

Aug 11, 2022

SELL
$213.86 - $277.87 $2,780 - $3,612
-13 Reduced 1.01%
1,278 $300,000
Q1 2022

May 16, 2022

BUY
$259.82 - $298.18 $13,250 - $15,207
51 Added 4.11%
1,291 $340,000
Q4 2021

Feb 09, 2022

BUY
$271.6 - $314.21 $4,345 - $5,027
16 Added 1.31%
1,240 $390,000
Q3 2021

Nov 15, 2021

SELL
$274.82 - $308.34 $53,864 - $60,434
-196 Reduced 13.8%
1,224 $344,000
Q1 2021

May 07, 2021

BUY
$204.88 - $255.03 $290,929 - $362,142
1,420 New
1,420 $362,000
Q3 2020

Nov 04, 2020

SELL
$167.03 - $201.3 $271,757 - $327,515
-1,627 Closed
0 $0
Q2 2020

Aug 05, 2020

SELL
$113.31 - $182.44 $20,395 - $32,839
-180 Reduced 9.96%
1,627 $270,000
Q1 2020

May 06, 2020

BUY
$104.32 - $195.28 $188,506 - $352,870
1,807 New
1,807 $228,000
Q1 2019

May 01, 2019

SELL
$123.7 - $156.3 $409,075 - $516,884
-3,307 Closed
0 $0
Q4 2018

Feb 04, 2019

BUY
$120.82 - $174.09 $1,087 - $1,566
9 Added 0.27%
3,307 $418,000
Q3 2018

Oct 25, 2018

BUY
$167.67 - $188.27 $40,408 - $45,373
241 Added 7.88%
3,298 $573,000
Q2 2018

Aug 02, 2018

BUY
$160.33 - $189.41 $490,128 - $579,026
3,057 New
3,057 $549,000
Q2 2018

Jul 25, 2018

SELL
$160.33 - $189.41 $441,228 - $521,256
-2,752 Closed
0 $0
Q1 2018

May 01, 2018

BUY
$161.53 - $178.11 $444,530 - $490,158
2,752 New
2,752 $445,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.